Biotech RadarJobs updated

COMPANY

Vivani Medical

HQ: Alameda, CA source · vivani.com ↗ · West Coast

Clinical Phase 1

Location: Alameda, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Obesity & Overweight Overweight and Obesity Type2diabetes

$28.4MRaised (2 yrs)2Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant source ↗
  2. Raise Follow-on offering: $4.5M (total, as published), announced Jan 27, 2026. Source: SEC filing. source ↗
  3. Raise Follow-on offering: $15.7M (total, as published), announced Oct 28, 2025. Source: SEC filing. source ↗
  4. Partnership Partnership / licensing announced Apr 15, 2025. Source: SEC filing. source ↗
  5. Raise Private placement: $8.25M (total, as published), announced Mar 27, 2025. Source: company's own press page. source ↗
  6. Trial start Phase 1: Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Raised: $28.4M. Last 2 years.

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07430059Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide ImplantPhase 1Not yet recruiting2026-072026-12 (estimated)
NCT05670379Assessment of Safety, Tolerability and Drug Levels of Exenatide ImplantPhase 1CompletedDec 20, 2024Aug 21, 2025 (actual)
Feedback